Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Crystal structures of 4-{(E)-3-[(imino-λ5-aza-nyl-idene)amino]-prop-1-en-yl}-N,N-di-methyl-imidazole-1-sulfonamide and 2-[(imino-λ5-aza-nyl-idene)amino]-4-{(E)-3-[(imino-λ5-aza-nyl-idene)amino]-prop-1-en-yl}-N,N-di-methyl-imidazole-1-sulfonamide.

Cruz LM, Moore RY, Gutierrez MT, Herath AK, Lovely CJ, Yousufuddin M.

Acta Crystallogr E Crystallogr Commun. 2019 Apr 25;75(Pt 5):695-699. doi: 10.1107/S205698901900519X. eCollection 2019 May 1.

2.

Calretinin Neurons in the Rat Suprachiasmatic Nucleus.

Moore RY.

J Biol Rhythms. 2016 Aug;31(4):406-10. doi: 10.1177/0748730416654024. Epub 2016 Jun 21.

PMID:
27330050
3.

The suprachiasmatic nucleus and the circadian timing system.

Moore RY.

Prog Mol Biol Transl Sci. 2013;119:1-28. doi: 10.1016/B978-0-12-396971-2.00001-4. Review.

PMID:
23899592
4.

Innervation of ventricular and periventricular brain compartments.

Leak RK, Moore RY.

Brain Res. 2012 Jun 29;1463:51-62. doi: 10.1016/j.brainres.2012.04.055. Epub 2012 May 7.

5.

In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.

Pavese N, Moore RY, Scherfler C, Khan NL, Hotton G, Quinn NP, Bhatia KP, Wood NW, Brooks DJ, Lees AJ, Piccini P.

Exp Neurol. 2010 Mar;222(1):120-4. doi: 10.1016/j.expneurol.2009.12.021. Epub 2010 Jan 4.

PMID:
20043906
6.

Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.

Bohnen NI, Gedela S, Herath P, Constantine GM, Moore RY.

Neurosci Lett. 2008 Dec 5;447(1):12-6. doi: 10.1016/j.neulet.2008.09.070. Epub 2008 Sep 30.

7.

Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease.

Hall AM, Moore RY, Lopez OL, Kuller L, Becker JT.

Alzheimers Dement. 2008 Jul;4(4):271-9. doi: 10.1016/j.jalz.2008.04.005.

8.

Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study.

Bohnen NI, Studenski SA, Constantine GM, Moore RY.

Eur J Neurol. 2008 Jul;15(7):685-91. doi: 10.1111/j.1468-1331.2008.02148.x. Epub 2008 Apr 24.

PMID:
18435767
9.

Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.

Moore RY, Whone AL, Brooks DJ.

Neurobiol Dis. 2008 Mar;29(3):381-90. doi: 10.1016/j.nbd.2007.09.004. Epub 2007 Sep 26.

PMID:
18226536
10.

Gamma Knife thalamotomy for essential tremor.

Kondziolka D, Ong JG, Lee JY, Moore RY, Flickinger JC, Lunsford LD.

J Neurosurg. 2008 Jan;108(1):111-7. doi: 10.3171/JNS/2008/108/01/0111. Erratum in: J Neurosurg. 2008 Mar;108(3):635.

PMID:
18173319
11.

Suprachiasmatic nucleus in sleep-wake regulation.

Moore RY.

Sleep Med. 2007 Dec;8 Suppl 3:27-33. Review.

PMID:
18032104
12.

Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease.

Bohnen NI, Kuwabara H, Constantine GM, Mathis CA, Moore RY.

Neurosci Lett. 2007 Sep 13;424(3):185-9. Epub 2007 Aug 6.

13.

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.

Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, Moore RY.

J Neurol. 2007 Jan;254(1):84-90. Epub 2007 Feb 14.

PMID:
17508142
14.

Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia.

Bohnen NI, Kaufer DI, Hendrickson R, Constantine GM, Mathis CA, Moore RY.

J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):641-3.

15.

Diurnal variation in regional brain glucose metabolism in depression.

Germain A, Nofzinger EA, Meltzer CC, Wood A, Kupfer DJ, Moore RY, Buysse DJ.

Biol Psychiatry. 2007 Sep 1;62(5):438-45. Epub 2007 Jan 9.

16.

Lesions of suprachiasmatic nucleus efferents selectively affect rest-activity rhythm.

Abrahamson EE, Moore RY.

Mol Cell Endocrinol. 2006 Jun 27;252(1-2):46-56.

PMID:
16793198
17.

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Mathis ChA, Davis JG, Moore RY, Dekosky ST.

J Neurol. 2006 Feb;253(2):242-7. Epub 2005 Sep 2.

PMID:
16133720
18.

Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti B, Davis JG, Constantine G, Mathis CA, Moore RY, DeKosky ST.

Neurosci Lett. 2005 May 20-27;380(1-2):127-32. Epub 2005 Feb 8.

PMID:
15854764
19.

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, Dekosky ST, Moore RY.

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9.

20.

Predictive models of postural control based on electronic force platform measures in patients with Parkinson's disease.

Constantine GM, Buliga MG, Ivanco LS, Moore RY, Bohnen NI.

Int J Appl Math (Sofia). 2005;18(4):487-500.

21.

Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings.

Buysse DJ, Nofzinger EA, Germain A, Meltzer CC, Wood A, Ombao H, Kupfer DJ, Moore RY.

Sleep. 2004 Nov 1;27(7):1245-54.

PMID:
15586778
22.

The suprachiasmatic nucleus and sleep-wake regulation.

Moore RY.

Postgrad Med. 2004 Dec;116(6 Suppl Primary):6-9. doi: 10.3810/pgm.12.2004.suppl39.264.

PMID:
19667692
23.

Serotonin innervation of the primate suprachiasmatic nucleus.

Moore RY, Speh JC.

Brain Res. 2004 Jun 4;1010(1-2):169-73.

PMID:
15126131
24.

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, Mathis CA, Moore RY, DeKosky ST.

Arch Neurol. 2003 Dec;60(12):1745-8.

PMID:
14676050
25.

Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.

Thannickal TC, Siegel JM, Nienhuis R, Moore RY.

Brain Pathol. 2003 Jul;13(3):340-51.

PMID:
12946023
26.

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

Moore RY, Whone AL, McGowan S, Brooks DJ.

Brain Res. 2003 Aug 29;982(2):137-45.

PMID:
12915249
27.

Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease.

Moore RY.

Parkinsonism Relat Disord. 2003 Aug;9 Suppl 2:S65-71. Review.

PMID:
12915070
28.

Plasticity of the nigropallidal pathway in Parkinson's disease.

Whone AL, Moore RY, Piccini PP, Brooks DJ.

Ann Neurol. 2003 Feb;53(2):206-13.

PMID:
12557287
29.

Suprachiasmatic nucleus organization.

Moore RY, Speh JC, Leak RK.

Cell Tissue Res. 2002 Jul;309(1):89-98. Epub 2002 Jun 8.

PMID:
12111539
30.

Paraventricular-subparaventricular hypothalamic lesions selectively affect circadian function.

Moore RY, Danchenko RL.

Chronobiol Int. 2002 Mar;19(2):345-60.

PMID:
12025929
31.

Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking.

Nofzinger EA, Buysse DJ, Miewald JM, Meltzer CC, Price JC, Sembrat RC, Ombao H, Reynolds CF, Monk TH, Hall M, Kupfer DJ, Moore RY.

Brain. 2002 May;125(Pt 5):1105-15.

PMID:
11960899
32.
33.

The hypocretin neuron system: an arousal system in the human brain.

Moore RY, Abrahamson EA, Van Den Pol A.

Arch Ital Biol. 2001 Apr;139(3):195-205.

PMID:
11330201
34.

Topographic organization of suprachiasmatic nucleus projection neurons.

Leak RK, Moore RY.

J Comp Neurol. 2001 May 7;433(3):312-34.

PMID:
11298358
35.

The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems.

Abrahamson EE, Leak RK, Moore RY.

Neuroreport. 2001 Feb 12;12(2):435-40.

PMID:
11209963
36.

The posterior hypothalamic area: chemoarchitecture and afferent connections.

Abrahamson EE, Moore RY.

Brain Res. 2001 Jan 19;889(1-2):1-22.

PMID:
11166682
37.

Efferent projections of the intergeniculate leaflet and the ventral lateral geniculate nucleus in the rat.

Moore RY, Weis R, Moga MM.

J Comp Neurol. 2000 May 8;420(3):398-418.

PMID:
10754510
38.

Reduced number of hypocretin neurons in human narcolepsy.

Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM.

Neuron. 2000 Sep;27(3):469-74.

39.

Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies.

Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, Kupfer DJ, Moore RY.

Psychiatry Res. 1999 Aug 31;91(2):59-78. Review.

PMID:
10515462
40.

A clock for the ages.

Moore RY.

Science. 1999 Jun 25;284(5423):2102-3. No abstract available.

PMID:
10409066
41.
42.

Molecular cloning and characterization of the human CLOCK gene: expression in the suprachiasmatic nuclei.

Steeves TD, King DP, Zhao Y, Sangoram AM, Du F, Bowcock AM, Moore RY, Takahashi JS.

Genomics. 1999 Apr 15;57(2):189-200.

PMID:
10198158
43.

Suprachiasmatic pacemaker organization analyzed by viral transynaptic transport.

Leak RK, Card JP, Moore RY.

Brain Res. 1999 Feb 20;819(1-2):23-32.

PMID:
10082857
44.

Suprachiasmatic nucleus organization.

Moore RY, Silver R.

Chronobiol Int. 1998 Sep;15(5):475-87. Review. No abstract available.

PMID:
9787937
45.

The suprachiasmatic nucleus and circadian function: an introduction.

Silver R, Moore RY.

Chronobiol Int. 1998 Sep;15(5):vii-x. Review. No abstract available.

PMID:
9787932
46.

A method for the assessment of the functional neuroanatomy of human sleep using FDG PET.

Nofzinger EA, Mintun MA, Price J, Meltzer CC, Townsend D, Buysse DJ, Reynolds CF 3rd, Dachille M, Matzzie J, Kupfer DJ, Moore RY.

Brain Res Brain Res Protoc. 1998 Mar;2(3):191-8.

PMID:
9507123
47.

Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.

Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF 3rd.

Neuropsychopharmacology. 1998 Jun;18(6):407-30. Review.

48.

Forebrain activation in REM sleep: an FDG PET study.

Nofzinger EA, Mintun MA, Wiseman M, Kupfer DJ, Moore RY.

Brain Res. 1997 Oct 3;770(1-2):192-201.

PMID:
9372219
49.
50.

Organization of neural inputs to the suprachiasmatic nucleus in the rat.

Moga MM, Moore RY.

J Comp Neurol. 1997 Dec 22;389(3):508-34.

PMID:
9414010

Supplemental Content

Loading ...
Support Center